MECHANISMS INVOLVED IN IONTOPHORETIC TRANSPORT OF ANGIOTENSIN

被引:15
作者
CLEMESSY, M
COUARRAZE, G
BEVAN, B
PUISIEUX, F
机构
[1] UNIV PARIS SUD,CTR PHARMACEUT,CNRS,URA 1218,F-92290 CHATENAY MALABRY,FRANCE
[2] LABS FOURNIER SCA,F-21300 CHENOVE,FRANCE
关键词
IONTOPHORESIS; IONTOHYDROKINESIS; ANGIOTENSIN; 2; TRANSDERMAL DELIVERY; DIRECT CURRENT; PULSED CURRENT;
D O I
10.1023/A:1016254230155
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The feasibility of using iontophoresis to enhance the permeation rate of a model peptide was investigated in vitro using hairless mouse skin. Methods. Angiotensin 2 (AT 2) was employed as a permeant probe, using optimum iontophoresis conditions. A number of physicochemical parameters (donor ionic strength; valence of competitive ions; pH of donor solution) were studied with the aim of exploring the mechanisms involved in the iontophoretic transport through the skin: electrokinetic transport or convective transport. For this purpose, the magnitude of the convective solvent flow was also evaluated by the permeation of (H-3) H2O. The interest of pulsed currents for peptide delivery was also investigated and the effect of current density and frequency was studied. Results. AT 2 transport was found to be enhanced 20-fold in comparison to passive permeation and was found to be proportional to the current density with direct currents as with pulsed currents. Conclusions. Although the nux enhancement of ions during iontophoresis is due principally to the electrical potential gradient, secondary effects such as convective solvent flow contribute also to flux enhancement of peptide delivery. This effect is dependent of physicochemical conditions of formulation.
引用
收藏
页码:998 / 1002
页数:5
相关论文
共 15 条
[1]   IONTOPHORETICALLY INDUCED TRANSDERMAL DELIVERY OF SALBUTAMOL [J].
BANNON, YB ;
CORISH, J ;
CORRIGAN, OI ;
MASTERSON, JG .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (15-17) :2151-2166
[2]  
BARRY PH, 1969, BIOPHYS J, P729
[3]   COMPARISON BETWEEN THE IONTOPHORETIC AND PASSIVE TRANSPORT OF THYROTROPIN-RELEASING-HORMONE ACROSS EXCISED NUDE-MOUSE SKIN [J].
BURNETTE, RR ;
MARRERO, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (08) :738-743
[4]   CHARACTERIZATION OF THE PERMSELECTIVE PROPERTIES OF EXCISED HUMAN-SKIN DURING IONTOPHORESIS [J].
BURNETTE, RR ;
ONGPIPATTANAKUL, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (10) :765-773
[5]   PRESERVATION OF SKIN PERMEABILITY DURING IN-VITRO IONTOPHORETIC EXPERIMENTS [J].
CLEMESSY, M ;
COUARRAZE, G ;
BEVAN, B ;
PUISIEUX, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 101 (03) :219-226
[6]  
GANGAROSA LP, 1980, J PHARMACOL EXP THER, V212, P377
[7]  
GREEN PG, 1991, PHARMACEUT RES, V8, P9
[8]  
KIM A, 1993, PHARMACEUT RES, V10, P9
[9]   TRANSDERMAL IONTOPHORETIC DELIVERY OF ARGININE-VASOPRESSIN .1. PHYSICOCHEMICAL CONSIDERATIONS [J].
LELAWONGS, P ;
LIU, JC ;
SIDDIQUI, O ;
CHIEN, YW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 56 (01) :13-22
[10]   TRANSDERMAL IONTOPHORETIC DELIVERY OF ARGININE-VASOPRESSIN .2. EVALUATION OF ELECTRICAL AND OPERATIONAL FACTORS [J].
LELAWONGS, P ;
LIU, JC ;
CHIEN, YW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 61 (03) :179-188